SNHG12, also known by other names (LNC04080, ASLNC04080, C1orf79, LINC00100, PNAS-1230), was overexpressed in several cancers, including non-small-cell lung cancer, renal cell carcinoma, and prostate cancer, and its levels correlated with tumor size, progression, and metastasis [66]. Here, SNHG12 is linked to neoplasm.